DE69831785D1 - Tulobuterol enthaltendes Präparat für perkutane Absorption - Google Patents

Tulobuterol enthaltendes Präparat für perkutane Absorption

Info

Publication number
DE69831785D1
DE69831785D1 DE69831785T DE69831785T DE69831785D1 DE 69831785 D1 DE69831785 D1 DE 69831785D1 DE 69831785 T DE69831785 T DE 69831785T DE 69831785 T DE69831785 T DE 69831785T DE 69831785 D1 DE69831785 D1 DE 69831785D1
Authority
DE
Germany
Prior art keywords
percutaneous absorption
tulobuterol
time
preparation
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69831785T
Other languages
English (en)
Other versions
DE69831785T2 (de
Inventor
Yoshihisa Nakano
Mitsuhiko Hori
Keiji Yamamoto
Saburo Otsuka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nitto Denko Corp
Abbott Japan Co Ltd
Original Assignee
Nitto Denko Corp
Abbott Japan Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Denko Corp, Abbott Japan Co Ltd filed Critical Nitto Denko Corp
Application granted granted Critical
Publication of DE69831785D1 publication Critical patent/DE69831785D1/de
Publication of DE69831785T2 publication Critical patent/DE69831785T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69831785T 1997-12-12 1998-12-08 Tulobuterol enthaltendes Präparat für perkutane Absorption Expired - Lifetime DE69831785T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP34258297 1997-12-12
JP34258297 1997-12-12
JP30449898A JP3930984B2 (ja) 1997-12-12 1998-10-26 経皮吸収型製剤
JP30449898 1998-10-26

Publications (2)

Publication Number Publication Date
DE69831785D1 true DE69831785D1 (de) 2006-02-16
DE69831785T2 DE69831785T2 (de) 2006-07-13

Family

ID=26563935

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69831785T Expired - Lifetime DE69831785T2 (de) 1997-12-12 1998-12-08 Tulobuterol enthaltendes Präparat für perkutane Absorption

Country Status (14)

Country Link
US (1) US6117447A (de)
EP (1) EP0922453B1 (de)
JP (1) JP3930984B2 (de)
KR (1) KR100610185B1 (de)
CN (1) CN1129426C (de)
AT (1) ATE305775T1 (de)
BR (1) BR9806470B1 (de)
CA (1) CA2255447C (de)
DE (1) DE69831785T2 (de)
DK (1) DK0922453T3 (de)
ES (1) ES2246062T3 (de)
HU (1) HU227974B1 (de)
PL (1) PL194195B1 (de)
PT (1) PT922453E (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3930984B2 (ja) * 1997-12-12 2007-06-13 日東電工株式会社 経皮吸収型製剤
DE19950066A1 (de) * 1999-10-16 2001-04-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einem Gehalt an Tulobuterol-hydrochlorid zur Verabreichung des Bronchodilatators Tulobuterol über die Haut
JP3711846B2 (ja) * 2000-07-27 2005-11-02 株式会社村田製作所 高周波モジュール及びそれを用いた移動体通信装置
US6517877B2 (en) * 2000-12-29 2003-02-11 Martin Francis Gannon Animal food product
KR100439659B1 (ko) * 2001-06-23 2004-07-12 제일약품주식회사 툴로부테롤을 함유하는 경피흡수용 패취제
KR100535302B1 (ko) * 2002-02-01 2005-12-08 주식회사 태평양 툴로부테롤 함유 경피흡수형 제제
KR100469995B1 (ko) * 2002-05-20 2005-02-05 안국약품 주식회사 천식치료제를 함유한 매트릭스형 패취
JP2004224701A (ja) * 2003-01-17 2004-08-12 Yuutoku Yakuhin Kogyo Kk 外用貼付剤
JP2004224741A (ja) * 2003-01-23 2004-08-12 Hisamitsu Pharmaceut Co Inc ツロブテロール経皮吸収型製剤
JP4617069B2 (ja) * 2003-06-16 2011-01-19 コスメディ製薬株式会社 貼付剤
JP4647490B2 (ja) 2003-06-20 2011-03-09 帝國製薬株式会社 ツロブテロール含有貼付剤
KR20060100411A (ko) * 2003-11-21 2006-09-20 세키스이가가쿠 고교가부시키가이샤 부착제
CN1297257C (zh) * 2004-01-02 2007-01-31 上海现代药物制剂工程研究中心有限公司 含有妥洛特罗的压敏胶，透皮贴剂及制备方法和应用
CA2552679C (en) * 2004-01-20 2012-12-11 Saitama Daiichi Pharmaceutical Co., Ltd. Tulobuterol adhesive patch
KR100579721B1 (ko) 2004-09-15 2006-05-15 (주) 에프디엘 툴로부테롤을 함유하는 경피투여용 패취제
JP2006206471A (ja) * 2005-01-26 2006-08-10 Nitto Denko Corp テープ製剤
US9381279B2 (en) 2005-03-24 2016-07-05 Abbott Cardiovascular Systems Inc. Implantable devices formed on non-fouling methacrylate or acrylate polymers
US7700659B2 (en) 2005-03-24 2010-04-20 Advanced Cardiovascular Systems, Inc. Implantable devices formed of non-fouling methacrylate or acrylate polymers
JP5058531B2 (ja) * 2005-09-09 2012-10-24 日東電工株式会社 ビソプロロール含有貼付製剤
JP4945228B2 (ja) 2005-12-13 2012-06-06 日東電工株式会社 ビソプロロール含有貼付製剤
KR20090118957A (ko) * 2007-03-08 2009-11-18 닛토덴코 가부시키가이샤 비소프롤롤 경피 투여 디바이스
KR100956023B1 (ko) * 2007-09-28 2010-05-06 대화제약 주식회사 산성 관능기를 갖는 아크릴레이트계 고분자의 함량으로약물 방출속도를 제어하는 툴로부테롤 경피 투여용 패취제
JP2009286707A (ja) * 2008-05-27 2009-12-10 Nitto Denko Corp 医療材料又は衛生材料用のゲル組成物、その成形体及びそれを用いた貼付材もしくは貼付製剤
JP5432613B2 (ja) * 2008-07-17 2014-03-05 日東電工株式会社 貼付剤および貼付製剤
JP5432614B2 (ja) * 2008-07-17 2014-03-05 日東電工株式会社 貼付剤および貼付製剤
JP2010241746A (ja) * 2009-04-07 2010-10-28 Nitto Denko Corp 貼付剤および貼付製剤
JP5404145B2 (ja) * 2009-04-10 2014-01-29 日東電工株式会社 貼付剤および貼付製剤
JP5766475B2 (ja) * 2010-03-30 2015-08-19 日東電工株式会社 貼付製剤およびその製造方法
WO2012103016A2 (en) * 2011-01-26 2012-08-02 Csi Gmbh Extended-release beta agonist/anticholinergic transdermal patches and methods for using the same
WO2012103015A2 (en) * 2011-01-27 2012-08-02 Csi Gmbh Extended-release beta agonist/steroid transdermal patches and methods for using the same
CN103127032A (zh) * 2011-11-30 2013-06-05 大化制药株式会社 妥洛特罗贴剂
US11179469B2 (en) 2017-04-28 2021-11-23 Nitto Denko Corporation Transdermal absorption preparation
CN115634216A (zh) * 2022-10-28 2023-01-24 湖北兵兵药业(集团)有限公司 一种妥洛特罗水凝胶贴剂及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300291A (en) * 1988-03-04 1994-04-05 Noven Pharmaceuticals, Inc. Method and device for the release of drugs to the skin
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
JPH0725669B2 (ja) * 1988-12-23 1995-03-22 日東電工株式会社 経皮投与用医薬製剤
DE4002281A1 (de) * 1990-01-26 1991-08-01 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit dem wirkstoff tulobuterol
IT1251469B (it) * 1991-07-15 1995-05-15 Zambon Spa Sistema terapeutico transdermale per la somministrazione di farmaci ad attivita' broncodilatante.
JP2753800B2 (ja) * 1994-04-14 1998-05-20 日東電工株式会社 経皮吸収型製剤
JP3604177B2 (ja) * 1994-09-14 2004-12-22 日東電工株式会社 経皮吸収製剤
JPH08295624A (ja) * 1995-04-26 1996-11-12 Read Chem Kk プラスター基剤、その製造方法、該基剤を使用した外用貼 付剤
JP3930984B2 (ja) * 1997-12-12 2007-06-13 日東電工株式会社 経皮吸収型製剤

Also Published As

Publication number Publication date
ATE305775T1 (de) 2005-10-15
CN1226422A (zh) 1999-08-25
HUP9802889A3 (en) 2001-04-28
EP0922453B1 (de) 2005-10-05
CA2255447C (en) 2006-01-24
JP3930984B2 (ja) 2007-06-13
CN1129426C (zh) 2003-12-03
BR9806470B1 (pt) 2012-03-20
PL194195B1 (pl) 2007-05-31
DE69831785T2 (de) 2006-07-13
EP0922453A3 (de) 1999-11-24
HUP9802889A2 (hu) 1999-06-28
US6117447A (en) 2000-09-12
JPH11228395A (ja) 1999-08-24
PT922453E (pt) 2005-11-30
CA2255447A1 (en) 1999-06-12
BR9806470A (pt) 2000-04-11
PL330212A1 (en) 1999-06-21
KR100610185B1 (ko) 2006-11-30
DK0922453T3 (da) 2005-11-07
ES2246062T3 (es) 2006-02-01
HK1022091A1 (en) 2000-07-28
HU9802889D0 (en) 1999-02-01
EP0922453A2 (de) 1999-06-16
HU227974B1 (en) 2012-07-30
KR19990062986A (ko) 1999-07-26

Similar Documents

Publication Publication Date Title
ATE305775T1 (de) Tulobuterol enthaltendes präparat für perkutane absorption
DK0674913T3 (da) Ikke-okklusivt klæbende plaster til påföring af medicament i huden
DK0740650T3 (da) Codrugs som metode til styret transport af lægemiddel
ATE184473T1 (de) Verwendung von glyzerin zur dämpfung der transdermalen arzneimittelverabreichung
CY1117668T1 (el) Φαρμακευτικες συστασεις περιλαμβανουσες ινσουλινη συμπλοκοποιημενη με μια δικετοπιπεραζινη
KR950702827A (ko) 부프로피온 함유 서방형 정제(sustained release tablets containing bupropion)
ATE89755T1 (de) Vorrichtung zur transdermalen applikation von medikamenten.
KR870006906A (ko) 피부투과식 약물투여장치
DE69401945D1 (de) Einarbeitung eines poly-n-vinylamids in ein transdermales system
DE59306283D1 (de) Wirkstoffpflaster für niedrigschmelzende und/oder flüchtige wirkstoffe
ATE222759T1 (de) Tranilast enthaltendes externum und verfahren zu dessen herstellung
US4830856A (en) Chelation product
KR950703972A (ko) 항혈전성 치료 및 암 예방을 위한 아세틸살리실산을 함유하는 경피 투여 시스템(transdermal administration system containing acetylsalicyliic acid for antithrombotic therapy and the prevention of cancer)
ATE255450T1 (de) Matrix für iontophorese
AU4923500A (en) Device and method for increasing the transdermal permeation of medicaments
ES2116572T3 (es) Parche para la administracion percutanea de sustancias de contenido quimicamente basico, farmaceuticamente eficaces y volatiles, y un metodo para su fabricacion.
ES2130446T3 (es) Sistema terapeutico transdermico que contiene octildodecanol como inhibidor de cristalizacion.
ATE220912T1 (de) Herstellung von st1435 enthaltenden pharmazeutischen zusammensetzungen zur topischen verwendung
JPS6468316A (en) External plaster containing salbutamol
ATE203906T1 (de) Zubereitung zur perkutanen verabreichung enthaltend 6-amino-5-chloro-1-isopropyl-2-(4- methyl-1-piperazinyl)benzimidazol
SE0103276L (sv) Anordning för administrering av salva till en hudyta
KR870005646A (ko) 수술후 유착형성 억제방법
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
BR0309375A (pt) Tratamento de sìndrome metabólica
TH25313A (th) องค์ประกอบทางเภสัชที่ออกฤทธิ์ผ่านทางผิวหนังที่มีกรด 5-แอมิโนเลฟวูลินิกประกอบอยู่

Legal Events

Date Code Title Description
8364 No opposition during term of opposition